methyltyrosine   Click here for help

GtoPdb Ligand ID: 5094

Synonyms: Demser® | DL-alpha-methyltyrosine | metyrosine
Approved drug
methyltyrosine is an approved drug (FDA (1979))
Comment: The INN for this compound is racemetirosine, indicating that it is a racemic mix of its R and S enantiomers. We show the non-isomeric structure to represent this mixture. The website rxlist.com describes the approved drug, Demser, as (-)-α-methyl-L-tyrosine, but shows a non-stereo molecular structure. We have annotated both versions (racemic and S-enantiomer (L or α) with the same US FDA approval date, as the exact compostion of the approved drug is unclear.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 3
Rotatable bonds 3
Topological polar surface area 83.55
Molecular weight 195.09
XLogP -1.68
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Oc1ccc(cc1)CC(C(=O)O)(N)C
Isomeric SMILES Oc1ccc(cc1)CC(C(=O)O)(N)C
InChI InChI=1S/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14)
InChI Key NHTGHBARYWONDQ-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Metyrosine is used to treat tumours of the adrenal gland known as pheochromocytoma. These tumours over-produce catecholamines and thereby cause hyperstimulation of the sympathetic nervous system.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
It is hypothesised that metyrosine disrupts the synthesis of catecholamines by acting as an inhibitor of tyrosine hydroxylase, with in vivo human results to support this hypothesis [1].